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Abstract
Tolerance to lipopolysaccharide (LPS) occurs when animals or cells exposed to LPS become hyporesponsive to a subsequent 
challenge with LPS. This mechanism is believed to be involved in the down-regulation of cellular responses observed in septic 
patients. The aim of this investigation was to evaluate LPS-induced monocyte tolerance of healthy volunteers using whole blood. 
The detection of intracellular IL-6, bacterial phagocytosis and reactive oxygen species (ROS) was determined by flow cytometry, 
using anti-IL-6-PE, heat-killed Staphylococcus aureus stained with propidium iodide and 2’,7’-dichlorofluorescein diacetate, 
respectively. Monocytes were gated in whole blood by combining FSC and SSC parameters and CD14-positive staining. The 
exposure to increasing LPS concentrations resulted in lower intracellular concentration of IL-6 in monocytes after challenge. 
A similar effect was observed with challenge with MALP-2 (a Toll-like receptor (TLR)2/6 agonist) and killed Pseudomonas 
aeruginosa and S. aureus, but not with flagellin (a TLR5 agonist). LPS conditioning with 15 ng/mL resulted in a 40% reduction 
of IL-6 in monocytes. In contrast, phagocytosis of P. aeruginosa and S. aureus and induced ROS generation were preserved 
or increased in tolerant cells. The phenomenon of tolerance involves a complex regulation in which the production of IL-6 was 
diminished, whereas the bacterial phagocytosis and production of ROS was preserved. Decreased production of proinflam-
matory cytokines and preserved or increased production of ROS may be an adaptation to control the deleterious effects of 
inflammation while preserving antimicrobial activity.
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Challenge with lipopolysaccharide (LPS) induces a wide 
range of biological responses in susceptible animals, includ-
ing the synthesis and release of inflammatory cytokines, 
reactive oxygen species (ROS) and reactive nitrogen spe-
cies (1). The biological activity of LPS may be modulated 
in vivo, and hypersensitivity and tolerance may be induced 
under experimental conditions (2).
The pre-exposure of an animal to low doses of LPS 
inhibits the biological response to a re-exposure to high 
doses of LPS, reducing the pathophysiological changes 
that are observed in normal hosts. Similar effects are also 
observed in cell cultures by re-exposure to LPS in vitro. 
This phenomenon is called endotoxin tolerance, although 
other terms such as reprogramming, adaptation, anergy, 
or refractoriness are used in the literature (3).
Tolerance to endotoxin has been examined in a series 
of elegant experiments. It has been reported that periph-
eral blood cells of healthy humans exposed to LPS in vivo 
showed reduced production of tumor necrosis factor-alpha 
(TNF-α), interleukin (IL)-1β, IL-6, and IL-10 after further 
stimulation in vitro (4,5). Tominaga et al. (6) found a lower 
expression of mRNA for TNF-α and IL-6 in macrophages 
of tolerant mice in response to re-stimulation with LPS. 
However, other in vivo and in vitro studies evaluating en-
dotoxin tolerance have shown that the phenomenon is not 
a global down-regulation of macrophages, but a complex 
modulatory response. The re-exposure of monocytes and 
macrophages previously exposed to LPS showed lower 
gene expression of TNF-α, IL-1β, IL-6, IL-12, and Jun B, 
but other genes, including IL-10, IL-1R and tumor necrosis 
factor receptor II (TNFRII), are normally or highly expressed 
(for a review, see Ref. 7). 
Studies on circulating leukocytes of septic patients have 
shown reduced production of inflammatory cytokines after 
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in vitro stimulation, similar to what is found in cells made 
tolerant to LPS. Ertel et al. (8), using whole blood from 
septic patients, found a smaller production of TNF-α, IL-1β, 
and IL-6 after stimulation with LPS. This reduced cytokine 
production was extended to IL-4, IL-10, IL-12, interferon-
gamma (IFN-γ), and transforming growth factor-beta 
(TGF-β) (9). A study conducted by our group using a similar 
model confirmed the decreased production of TNF-α and 
IFN-γ in vitro; however, we found preserved production of 
IL-10 in patients with severe sepsis and septic shock (10). 
Brunialti et al. (11) demonstrated a positive regulation of the 
production of inflammatory cytokines at the onset of sepsis, 
followed by a prominent decline in more severe stages of 
the disease, severe sepsis and septic shock, showing that 
the cellular response may be modulated according to the 
stages of sepsis.
The induction of the phenotype of tolerance to endotoxin 
may be triggered by other family members of Toll-like recep-
tors (TLR)/IL-1R ligands, in addition to LPS and TLR4. The 
ability of a stimulus other than LPS to initiate the phenotype 
of tolerance is called cross-tolerance (12). Medvedev et al. 
(13) showed that pretreatment with IL-1β resulted in inhibi-
tion of activation of NF-κB and AP-1 in response to LPS. The 
conditioning of macrophages with other bacterial products 
such as lipoteichoic acid resulted in inhibited secretion of 
LPS-induced TNF-α (14). 
Invading pathogens are phagocytized and killed by a 
powerful arsenal of enzymes, cationic proteins, ROS, and 
reactive nitrogen species produced by the cell and released 
into the phagosomes (1). In animal models, in vivo and in 
vitro experiments have shown preserved phagocytosis 
and bacterial clearance in tolerant cells (15,16), while 
both reduced (17) and enhanced (18,19) nitric oxide (NO) 
generation has been reported. 
In a previous study by our group involving patients 
with severe sepsis and septic shock, we observed lower 
production of inflammatory cytokines by mononuclear 
cells after in vitro stimulation with LPS (11). However, the 
production of ROS in the same patients was increased in 
monocytes under basal conditions and after stimulation with 
PMA, fMLP, LPS, and Staphylococcus aureus compared to 
healthy volunteers (20). This finding revealed a dichotomy 
of the monocyte response in septic patients with down-
regulation of the production of inflammatory cytokines and 
up-regulation of ROS.
Since there are similarities between the functional 
modulations found in leukocytes of septic patients and in 
cells made tolerant to LPS, we investigated whether the 
same phenomenon occurs in tolerance induced in human 
whole blood in vitro.
Material and Methods
Healthy volunteers
The study was approved by the Ethics Research Com-
mittee of Universidade Federal de São Paulo, Hospital 
São Paulo (protocol #0121/06). Written informed consent 
was obtained from all volunteers. Blood samples from 17 
healthy volunteers (mean age, 29 ± 8 years; 82% females) 
were drawn into heparin-treated vacuum tubes (Becton 
Dickinson, UK). All volunteers reported being healthy and 
none were taking medication.
Reagents
LPS from Salmonella abortus equi, prepared by the 
phenol-water method and further purified with phenol-
chloroform-petroleum ether as previously described (21), 
was a gift from C. Galanos (Max-Planck Institute of Im-
munobiology, Germany). Macrophage-activating lipopep-
tide-2 (MALP-2) and flagellin were purchased from Alexis 
Biochemicals, Germany. Pseudomonas aeruginosa (ATCC 
27853) was purchased from Chrisope Technologies, UK, 
and S. aureus (ATCC 25923) was purchased from Difco, 
USA. The following monoclonal antibodies were used: 
CD66b-fluorescein isothyocyanate (FITC), clone G1OF5; 
CD14-peridinin-chlorophyll-protein (PerCP), clone MФP9; 
anti-IL-6-phycoerythrin (PE), clone AS14 (BD Bioscience, 
USA).
Induction of tolerance by LPS pretreatment
Heparinized blood was diluted 1:2 in RPMI (Sigma, USA) 
and divided into 2-mL aliquots. Samples were pretreated 
with increasing concentrations of LPS: 1, 7.5, 15, and 30 
ng/mL, or without LPS. After 18 h of incubation at 5%CO2 
at 37°C, the samples were mixed and divided into 4 aliquots 
(500 µL each) and then challenged with different TLR ago-
nists (LPS, MALP-2, flagellin) or Gram-positive (S. aureus) 
and Gram-negative (P. aeruginosa) bacteria (Figure 1). 
Intracellular detection of cytokines in monocytes in 
whole blood
After challenge with different TLR agonists, samples 
were transferred to 5-mL propylene tubes and incubated 
at 37°C in the presence of 5% CO2 for 5 h for intracellular 
detection of IL-6. After 30 min, 2 µL 1 mM monensin was 
added to the samples. Two hundred microliters of whole 
blood was washed in 2 mL phosphate-buffered saline (PBS) 
and centrifuged at 2500 g for 5 min at 4°C. Red blood cells 
were ruptured with 2 mL lysis solution (FACS lysing solution, 
BD Bioscience) for 10 min in the dark at room temperature 
followed by centrifugation at 2500 g for 5 min at 4°C. After 
washing with 2 mL PBS, samples were incubated with 
fluorochrome-conjugated monoclonal antibodies, CD66b-
FITC and CD14-PerCP, for surface staining for 15 min in the 
dark at room temperature. After centrifugation, the samples 
were washed in 2 mL PBS, centrifuged, and fixed with 1 
mL fixation buffer (PBS 4% paraformaldehyde) for 20 min 
in the dark at 4°C. After centrifugation, the supernatants 
were discarded, and 50 µL permeabilization buffer was then 
added (PBS 1% FCS; 0.1% sodium azide; 0.1% saponin) 
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plus anti-IL-6-PE. The tubes were incubated for 30 min in 
the dark at 4°C. After this time, the samples were washed 
with 2 mL permeabilization buffer and centrifuged. Super-
natants were discarded and cells were suspended in 0.3 
mL PBS 1% sodium azide.
Event acquisition and analyses were performed using 
the CellQuest software (BD Bioscience) and a FACSCalibur 
four-color flow cytometer (BD Bioscience). For each condition 
5000 events were acquired using forward- and side-scatter 
parameters combined with CD14-positive cells and CD66b-
negative cells. All events were acquired and stored.
Analysis of phagocytosis in tolerant and non-tolerant 
monocytes in whole blood
Phagocytosis was detected using heat-killed S. aureus 
stained with propidium iodide (PI; Sigma). Briefly, after inacti-
vation at high temperature, the bacteria were incubated with 
PI (5% concentrated) for 30 min in the dark at room tempera-
ture. The bacteria suspension was washed, resuspended in 
glycoside PBS solution and stored in aliquots of 2.4 x 109/
mL at -20°C until use. An aliquot (100 µL) of PI-labeled S. 
aureus was added to 200 µL whole blood, pretreated or not 
with LPS for 18 h, and 700 µL PBS (Figure 1). The samples 
were incubated at 37°C in a shaking water bath for 30 min. 
Thereafter, 2 mL PBS 3 mM EDTA (Sigma) was added to 
each tube followed by centrifugation at 250 g for 5 min at 4°C. 
Hypotonic lyses in saline (0.2 and 1.6%, Merck, Germany) 
were performed followed by centrifugation. Finally, the su-
pernatant was discarded and pellets were stained with 6 µL 
CD14-PerCP. After centrifugation, pellets were suspended in 
0.3 mL PBS 3 mM EDTA for flow cytometry analysis.
Monocytes were identified by side scatter and forward 
scatter parameters combined with positive staining for 
CD14. Monocyte phagocytosis was shown as the per-
centage of PI-stained cells and as the geometric mean of 
fluorescence intensity (GMFI).
Analysis of monocyte oxidative burst in whole blood 
after pretreatment with LPS and challenge with LPS, 
S. aureus or P. aeruginosa
Oxidative burst was quantified by measuring the oxida-
tion of 2’,7’-dichlorofluorescein diacetate (DCFH-DA, Sigma) 
in whole blood after pretreatment and challenge (Figure 1). 
Tubes containing 200 µL whole blood, stimuli, 200 µL 0.3 
mM DCFH-DA and PBS to complete 1 mL were incubated 
at 37°C in a shaking water bath for 30 min. The stimuli 
added were LPS (250 ng/mL), S. aureus (24 x 106/mL) or 
P. aeruginosa (12 x 106/mL). The samples were processed 
as described above. 
Monocytes were identified by side scatter and forward scat-
ter parameters and positive staining for CD14. ROS generation 
was shown in histograms and reported as the GMFI.
Statistical analysis
The Kolmogorov-Smirnov test was applied to determine 
whether distribution was normal. Continuous variables were 
described as median and range and represented in box-plot 
graphs. Differences among groups were tested by ANOVA 
plus the Bonferroni’s post hoc test. A P value of ≤0.05 was 
considered to be significant. Analysis was performed using 
the SPSS package, version 13.0 (USA). 
Results
Production of IL-6 by monocytes conditioned with  
increasing concentrations of LPS and challenged 
with different TLR agonists and whole bacteria
Peripheral blood cells were conditioned with small doses 
Figure 1. Schedule for the induction of tolerance in vitro. Heparinized blood was diluted 1:2 in RPMI and divided into aliquots. To induce 
tolerance, the samples were incubated with low concentrations of lipopolysaccharide (LPS) or without LPS (control). After 18 h of in-
cubation, samples were re-stimulated with different TLR agonists. Then, production of interleukin-6, phagocytosis and reactive oxygen 
species (ROS) generation in monocytes was measured by flow cytometry. MALP-2 = macrophage-activating lipopeptide-2.
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of LPS and challenged with different TLR agonists: LPS 
(TLR4), MALP-2 (TLR2/6), flagellin (TLR5), and whole 
Gram-negative (P. aeruginosa) and Gram-positive (S. 
aureus) killed bacteria. 
Detection of IL-6 in monocytes in whole blood was 
modulated by conditioning with low LPS concentrations 
(P < 0.001). Pre-exposure of peripheral blood to the 
concentrations of 7.5 and 30 ng/mL LPS resulted in a 
lower detection of intracellular IL-6 in monocytes after 
challenge with 100 ng/mL LPS compared to the detec-
tion in non-conditioned monocytes (P < 0.05; Figure 
2A). Pre-exposure to LPS also led to a decreased IL-6 
production by monocytes after challenge with a TLR2/6 
agonist (MALP-2; P < 0.001). Conditioning with 15 and 30 
ng/mL LPS resulted in the detection of less intracellular 
IL-6 in monocytes after challenge with MALP-2 compared 
to control non-conditioned cells (P < 0.05; Figure 2B). 
Increasing concentrations of LPS used for pre-exposure 
resulted in greater inhibition of IL-6 production. Accordingly, 
a decrease in the detection of the cytokine was found at 
a dose of 30 ng/mL in comparison to conditioning with 
7.5 ng/ml LPS (P < 0.05; Figure 2B). When the TLR5 
agonist flagellin was used as the challenge stimulus on 
monocytes conditioned with different concentrations of 
LPS no decrease in the production of IL-6 was observed 
(P = 0.946; Figure 2C). 
Pre-exposure of monocytes to LPS modulated the in-
duction of IL-6 by S. aureus (P = 0.001) and P. aeruginosa 
(P < 0.001). Conditioning with concentrations of 15 and 
30 ng/mL LPS resulted in a lower detection of intracellu-
lar IL-6 in monocytes after challenge with S. aureus (P < 
0.05; Figure 2D) and P. aeruginosa (P < 0.05; Figure 2E) 
compared to the detection in cells without conditioning. 
Analysis of phagocytosis in tolerant and 
non-tolerant monocytes in whole blood
No difference in phagocytosis of PI-labeled S. aureus 
was found between monocytes conditioned with 7.5 and 
15 ng/mL LPS and without pre-exposure to LPS in the per-
centage of positive-stained monocytes (P = 0.956; Figure 
3A, left) or in the intensity of fluorescence of S. aureus 
phagocytosing cells (P = 0.263; Figure 3A, right). 
ROS production by tolerant and non-tolerant 
monocytes in whole blood 
ROS generation after LPS challenge (250 ng/mL) was 
similar in monocytes conditioned with 7.5 and 15 ng/mL 
(GMFI: median = 27.8, range = 19.7-35.8, and median = 
40.0, range = 28.2-68.4, respectively) compared to non- 
conditioned monocytes (GMFI: median = 28.5, range = 
16.5-39.9; P = 0.162). Pre-exposure to LPS and challenge 
with S. aureus (P = 0.05; Figure 3B, left) resulted in in-
creased ROS generation in monocytes while no difference 
was found with challenge with P. aeruginosa (P = 0.217; 
Figure 3B, right).
Discussion
We evaluated the tolerance to LPS and cross-tolerance 
to other TLR agonists in monocytes present in human 
whole blood, thus mimicking the microenvironment of 
LPS-cell interaction as it occurs in vivo. Information about 
the effects of tolerance at the cellular level, measured by 
production of IL-6, phagocytosis and ROS generation by 
monocytes, was obtained using flow cytometry. Previous 
studies of induction of in vitro tolerance have evaluated 
macrophages and cells of different mouse tissues (6,8), and 
peripheral blood mononuclear cells, alveolar macrophages 
or blood from healthy individuals (4,5,11) exposed in vivo 
and in vitro to LPS. 
Studies with monocytes and macrophages of patients 
with severe sepsis and septic shock showed reduced pro-
duction of inflammatory cytokines after in vitro stimulation 
with LPS (8-10), a phenomenon that has similarities to 
tolerance induced by pre-exposure to LPS (3). 
One hypothesis to explain this phenomenon would be 
the modulation of soluble proteins or cell surface receptors 
that are responsible for LPS carrying and cell recognition. 
Accordingly, previous reports have shown changes in plasma 
concentrations of proteins regulating the biological action of 
LPS (22) and decreased expression of CD14 on the surface 
of monocytes (23), among others. Nomura et al. (24) studied 
the expression of TLR4 in macrophages of mice tolerant to 
LPS and found a correlation between the reduction in the 
expression of TLR4 and the fall in production of IL-6, indicating 
a modulation at the cell membrane level. A previous study by 
our group showed no difference in the binding of LPS to the 
cell membrane of monocytes of septic patients compared 
to healthy individuals. However, there was a significant 
impairment of TNF-α production, detected intracellularly in 
monocytes by flow cytometry, suggesting that regulation 
occurs in the cell signaling cascade (25,26).
Our results show that pre-exposure to small amounts 
of LPS was able to induce tolerance in peripheral blood 
monocytes in whole blood of human volunteers challenged 
with high concentrations of LPS. Other studies using hu-
man peripheral blood cells showed a reduced production 
of inflammatory cytokines (4,5). The decreased response 
to LPS can be explained by the presence of several intra-
cellular proteins that suppress the inflammatory response, 
regulating the cascade of negative signaling, and by differ-
ent combinations of NF-κB hetero- and homodimers that 
modulate gene expression under inflammatory or endotoxin- 
tolerant conditions (for a review, see Ref. 27). In addition to 
the idea of blocking the signaling and gene transcription, it 
has been proposed that the tolerance phenotype is caused 
by increased production of anti-inflammatory factors (28). 
Recently, it was demonstrated that another mechanism 
is involved in tolerance, comprising epigenetic changes 
able to regulate the expression of isolated genes from a 
pathway (29).
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Figure 2. Interleukin-6 (IL-6) detection in monocytes conditioned with lipopolysaccharide (LPS) and challenged with Toll-like receptor (TLR) 
agonists and whole bacteria. Peripheral blood cells were conditioned with low concentrations of LPS for 18 h and challenged with different 
TLR agonists: LPS (TLR4) (A), macrophage-activating lipopeptide-2 (MALP-2) (TLR2/6) (B), flagellin (TLR5) (C), and whole Gram-positive (S. 
aureus) (D) and Gram-negative (P. aeruginosa) (E) killed bacteria. For the detection of intracellular IL-6, whole blood samples were stimulated 
for 6 h. Monocytes were identified by forward scatter and side scatter parameters, CD14-positive staining and intracellular detection of IL-6 
on monocytes performed by flow cytometry. *P < 0.05 compared to no pretreatment (ANOVA followed by the Bonferroni’s test). +P < 0.05 
compared to pretreatment with 7.5 ng/mL LPS (ANOVA followed by the Bonferroni’s test). N = 5 for three different experiments.
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Once tolerance was demonstrated to LPS, a TLR4 
agonist, in the model of whole blood in vitro, we tested 
whether this effect occurs with TLR2/6 and TLR5 agonists. 
The pre-exposure to LPS led to a reduction of IL-6 produc-
tion in peripheral blood monocytes after challenge with the 
TLR2/6 agonist MALP-2. This finding agrees with Sato 
and colleagues (30), who observed reduced production of 
TNF-α in peritoneal macrophages of mice pre-exposed to 
LPS and challenged with MALP-2. However, the produc-
tion of this cytokine was increased when both MALP-2 and 
LPS were simultaneously added to the culture of peritoneal 
macrophages, showing a synergistic effect between these 
agonists. Conversely, Dobrovolskaia et al. (12) demon-
strated that conditioning with LPS from Escherichia coli and 
challenge with LPS from Porphyromonas gingivalis (a TLR2 
agonist) were not able to reduce the production of TNF-α in 
peritoneal macrophages of mice, the same occurring when 
the cells were conditioned with E. coli LPS and challenged 
with Pam3Cys (a TLR2/1 agonist) (12). 
Conditioning with LPS did not change the production 
of IL-6 after a challenge with flagellin (a TLR5 agonist). A 
possible explanation for the lack of tolerance is the use of 
an alternative pathway of cell signaling by flagellin that was 
not inhibited by pre-exposure to LPS. One possibility that 
may be considered is the recognition of flagellin directly 
in the cytoplasm of the cell by Ipaf, a NOD like-receptor, 
Figure 3. Phagocytosis and reactive oxygen species (ROS) generation by human tolerant monocytes. For monocyte phagocytosis, 
whole blood was stimulated for 30 min with S. aureus-propidium iodide (PI) after pretreatment with or without lipopolysaccharide (LPS; 
control). Monocyte phagocytosis was shown as the percentage of stained cells (A, left) and as the geometric mean of the fluorescence 
intensity (GMFI) (A, right). For induction of ROS, whole blood was stimulated for 30 min with 24 x 106/mL Staphylococcus aureus (B, 
left) and 12 x 106/mL Pseudomonas aeruginosa (B, right) after pretreatment with or without LPS (control). ROS production was mea-
sured by flow cytometry using 2’,7’-dichlorofluorescein-diacetate detection. *P = 0.05 compared to no pretreatment (ANOVA followed 
by the Bonferroni’s test). N = 5 for three different experiments.
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which activates the caspase-1 and triggers the release 
of inflammatory cytokines (31,32). Thus, cross-tolerance 
seems to depend on the cell type studied, the model used, 
and the concentration, sequence of conditioning and the 
stimulus.
After evaluating the modulatory effect of pre-exposure 
to LPS on the induction of IL-6 by TLR4, TLR2/6 and TLR5 
agonists, we assessed the effects of pre-exposure to LPS 
on the response to Gram-positive and Gram-negative 
bacteria, where multiple mechanisms of cellular activation 
are present. We chose to use S. aureus (a Gram-positive 
bacterium) and P. aeruginosa (a Gram-negative bacterium), 
common agents of infections in patients admitted to inten-
sive care units (33). 
Conditioning with increasing concentrations of LPS 
resulted in the detection of lower amounts of IL-6 in 
monocytes challenged with Staphylococcus aureus. This 
result agrees with Kreutz et al. (34) who showed induction 
of cross-tolerance between LPS and S. aureus in human 
monocytes by decreasing the production of TNF-α. In 
contrast, Peck et al. (35) found increased production of 
TNF-α, IL-6, IL-8, and IL-1β and unchanged production of 
granulocyte macrophage colony-stimulating factor (GM-
CSF) in THP-1 cells conditioned with LPS and challenged 
with S. aureus. 
The challenge with P. aeruginosa resulted in lower 
detection of intracellular IL-6 after conditioning with LPS in 
monocytes of peripheral blood. Corroborating these data, 
we found a lower production of TNF-α induced by P. aerugi-
nosa in peripheral blood cells of septic patients compared 
to healthy volunteers (10). Thus, the modulation of cells 
of septic patients during infection again shows similarities 
with tolerance induced in whole blood in vitro. 
In previous studies involving patients with severe sepsis 
and septic shock, we observed a dichotomy in mononuclear 
cell modulation, with lower production of inflammatory 
cytokines after stimulation with LPS, and preserved or in-
creased production of ROS (11,20). To check whether this 
phenomenon was also observed in monocytes of healthy 
volunteers conditioned in vitro with LPS, we assessed 
phagocytosis and ROS generation induced by challenge 
with LPS, P. aeruginosa and S. aureus. Pre-exposure to 
LPS did not alter the percentage of monocytes phago-
cytosing bacteria or the GMFI of positively stained cells, 
indicating that both the proportion of phagocytosing cells 
and the amount of phagocytosed bacteria are preserved. 
Conditioning with LPS did not alter the production of ROS 
in monocytes challenged with P. aeruginosa or LPS, and an 
even increased production of ROS was detected in mono-
cytes challenged with S. aureus. Thus, we demonstrated 
that monocytes of healthy individuals tolerant to LPS show 
the same dichotomy that we observed in septic patients. 
These results in humans are supported by experimental 
evidence showing that animals tolerant to LPS present 
preserved bacterial clearance (15), and preserved oxidative 
stress response and NO production (36). The presence of 
antimicrobial peptides produced by cells during sepsis or 
after exposure to LPS in vitro could support these findings. 
It has been shown that pre-incubation with antimicrobial 
peptides increases respiratory burst in murine (RAW 264.7) 
and human (THP-1) macrophage-like cell lines, while inhibit-
ing the release of TNF-α and NO induced by LPS (37). Our 
results also corroborated the findings of del Fresno et al. 
(38) who showed that human monocytes made tolerant to 
LPS and monocytes isolated from cystic fibrosis patients 
had high phagocytic activity and low production of inflam-
matory cytokines. This dichotomy fits the concept of Foster 
and co-workers (29) that gene regulation in cells made 
tolerant to LPS falls into two classes, the tolerizeable (T) 
and non-tolerizeable (NT) genes. The T genes, which are as-
sociated with pro-inflammatory genes, are down-regulated 
to protect against tissue damage, and the NT genes, which 
are associated with antimicrobial genes, remain inducible 
to protect against the microbes (29). 
In conclusion, the phenomenon of tolerance in human 
whole blood monocytes encompasses up- and down-
regulation of cellular activity. Decreased production of 
proinflammatory cytokines and preserved or increased 
production of ROS may be an adaptation driven to control 
the deleterious effects of inflammation, while preserving 
antimicrobial activity, corroborating a previous study on gene 
expression in tolerant cells (29). The similarities between 
the changes found in leukocytes of septic patients and in 
cells made tolerant to LPS in vitro indicate that this approach 
may be valuable for the understanding of the modulation 
of LPS-induced cell signaling during sepsis.
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